Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Gimmi, C D"'
Publikováno v:
Appropriate Dose Selection - How to Optimize Clinical Drug Development; 2007, p135-149, 15p
Publikováno v:
Cell Death & Differentiation; Jul2001, Vol. 8 Issue 7, p687, 9p
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; January 1992, Vol. 89 Issue: 1 p271-275, 5p
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; August 1991, Vol. 88 Issue: 15 p6575-6579, 5p
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; July 1993, Vol. 90 Issue: 14 p6586-6590, 5p
Autor:
Freeman, G J, Gray, G S, Gimmi, C D, Lombard, D B, Zhou, L J, White, M, Fingeroth, J D, Gribben, J G, Nadler, L M
Publikováno v:
The Journal of Experimental Medicine; September 1991, Vol. 174 Issue: 3 p625-631, 7p
Autor:
Gimmi CD; Global Pharma Development, Medical Sciences, F. Hoffmann-La Roche Ltd, Basel, Switzerland. Claude.Gimmi@Roche.com
Publikováno v:
Ernst Schering Research Foundation workshop [Ernst Schering Res Found Workshop] 2007 (59), pp. 135-49.
Targeting HER-2/neu for active-specific immunotherapy in a mouse model of spontaneous breast cancer.
Autor:
Céfaï D; Department of Clinical Research, University of Bern, Bern, Switzerland., Morrison BW, Sckell A, Favre L, Balli M, Leunig M, Gimmi CD
Publikováno v:
International journal of cancer [Int J Cancer] 1999 Oct 29; Vol. 83 (3), pp. 393-400.
Autor:
Gimmi CD; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA., Morrison BW, Mainprice BA, Gribben JG, Boussiotis VA, Freeman GJ, Park SY, Watanabe M, Gong J, Hayes DF, Kufe DW, Nadler LM
Publikováno v:
Nature medicine [Nat Med] 1996 Dec; Vol. 2 (12), pp. 1367-70.